| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $178.9M | -22.8% |
| Cost of Revenue | $147.5M | -18.0% |
| Gross Profit | $31.4M | -39.5% |
| R&D Expense | $27.3M | -46.7% |
| SG&A Expense | $35.1M | -25.4% |
| Operating Income | -$35.9M | +32.4% |
| Pre-tax Income | -$32.1M | +48.7% |
| Income Tax | -$17.9M | -114.6% |
| Net Income | -$29.7M | +45.3% |
| EPS (Basic) | -$0.82 | +43.1% |
| EPS (Diluted) | -$0.82 | +43.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.8M | -25.1% |
| Accounts Receivable | $26.0M | -8.4% |
| Inventory | $34.2M | +11.8% |
| Current Assets | $176.9M | -19.3% |
| Total Assets | $351.5M | -7.3% |
| Current Liabilities | $43.4M | -6.2% |
| Long-term Debt | $44.6M | +63.9% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.2M | -294.7% |
| Capital Expenditures | $30.0M | +158.6% |
| Investing Cash Flow | -$24.4M | -109.3% |
| Financing Cash Flow | $12.0M | -27.4% |
| Free Cash Flow | -$54.2M | -205.6% |
| $103.3M |
| +0.7% |
| Stockholders' Equity | $248.3M | -10.3% |